{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T18:06:18Z","timestamp":1785002778036,"version":"3.55.0"},"reference-count":41,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14392","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T11:03:53Z","timestamp":1712660633000},"source":"Crossref","is-referenced-by-count":2,"title":["Clinical prognostic significance of xeroderma pigmentosum group C and IFN\u2011\u03b3 in non\u2011small cell lung cancer"],"prefix":"10.3892","volume":"27","author":[{"given":"Yongming","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Translational Medical Center, Weifang Second People's Hospital (Weifang Respiratory Disease Hospital), Weifang, Shandong 261041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaijie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Translational Medical Center, Weifang Second People's Hospital (Weifang Respiratory Disease Hospital), Weifang, Shandong 261041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Translational Medical Center, Weifang Second People's Hospital (Weifang Respiratory Disease Hospital), Weifang, Shandong 261041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Translational Medical Center, Weifang Second People's Hospital (Weifang Respiratory Disease Hospital), Weifang, Shandong 261041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Translational Medical Center, Weifang Second People's Hospital (Weifang Respiratory Disease Hospital), Weifang, Shandong 261041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubing","family":"Wang","sequence":"additional","affiliation":[{"name":"Biopharmaceutical Laboratory, Key Laboratory of Shandong Province Colleges and Universities, School of Life Sciences and Technology, Weifang Medical University, Weifang, Shandong 261053, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changcheng","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Translational Medical Center, Weifang Second People's Hospital (Weifang Respiratory Disease Hospital), Weifang, Shandong 261041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Translational Medical Center, Weifang Second People's Hospital (Weifang Respiratory Disease Hospital), Weifang, Shandong 261041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongchao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"key":"key20240516111816_b1-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/CCO.0000000000000703","article-title":"Lung cancer in China: Current and prospect","volume":"33","author":"Wu","year":"2021","journal-title":"Curr Opin Oncol"},{"key":"key20240516111816_b2-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","article-title":"Lung Cancer 2020: Epidemiology, etiology, and prevention","volume":"41","author":"Bade","year":"2020","journal-title":"Clin Chest Med"},{"key":"key20240516111816_b3-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.dnarep.2013.08.013","article-title":"Xeroderma pigmentosum complementation group C protein (XPC) serves as a general sensor of damaged DNA","volume":"12","author":"Shell","year":"2013","journal-title":"DNA Repair (Amst)"},{"key":"key20240516111816_b4-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/carcin\/bgz003","article-title":"XPC protects against smoking- and carcinogen-induced lung adenocarcinoma","volume":"40","author":"Zhou","year":"2019","journal-title":"Carcinogenesis"},{"key":"key20240516111816_b5-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"8156","DOI":"10.3390\/ijms22158156","article-title":"Isoconazole and clemizole hydrochloride partially reverse the xeroderma pigmentosum C phenotype","volume":"22","author":"Kobaisi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20240516111816_b6-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1038\/sj.emboj.7601277","article-title":"New functions of XPC in the protection of human skin cells from oxidative damage","volume":"25","author":"D'Errico","year":"2006","journal-title":"EMBO J"},{"key":"key20240516111816_b7-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"561687","DOI":"10.3389\/fgene.2020.561687","article-title":"Xeroderma pigmentosum C (XPC) mutations in primary fibroblasts impair base excision repair pathway and increase oxidative DNA damage","volume":"11","author":"Fayyad","year":"2020","journal-title":"Front Genet"},{"key":"key20240516111816_b8-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"707940","DOI":"10.3389\/fphar.2021.707940","article-title":"XPC protein improves lung adenocarcinoma prognosis by inhibiting lung cancer cell stemness","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharmacol"},{"key":"key20240516111816_b9-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jgg.2015.09.006","article-title":"Genetic Evidence for XPC-KRAS interactions during lung cancer development","volume":"42","author":"Zhang","year":"2015","journal-title":"J Genet Genomics"},{"key":"key20240516111816_b10-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/14789450.2021.1892491","article-title":"Studies in lung cancer cytokine proteomics: A review","volume":"18","author":"Abolfathi","year":"2021","journal-title":"Expert Rev Proteomics"},{"key":"key20240516111816_b11-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"2138627","DOI":"10.1155\/2016\/2138627","article-title":"Proteomic-Based approaches for the study of cytokines in lung cancer","volume":"2016","author":"Marrugal","year":"2016","journal-title":"Dis Markers"},{"key":"key20240516111816_b12-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/ijc.31357","article-title":"IFN-\u04af-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling","volume":"143","author":"Gao","year":"2018","journal-title":"Int J Cancer"},{"key":"key20240516111816_b13-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s10147-017-1161-7","article-title":"PD-L1 induced by IFN-\u04af from tumor-associated macrophages via the JAK\/STAT3 and PI3K\/AKT signaling pathways promoted progression of lung cancer","volume":"22","author":"Zhang","year":"2017","journal-title":"Int J Clin Oncol"},{"key":"key20240516111816_b14-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"1962591","DOI":"10.1080\/2162402X.2021.1962591","article-title":"IFN-\u04af-induced ER stress impairs autophagy and triggers apoptosis in lung cancer cells","volume":"10","author":"Fang","year":"2021","journal-title":"Oncoimmunology"},{"key":"key20240516111816_b15-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.mcna.2018.12.006","article-title":"Lung cancer","volume":"103","author":"Nasim","year":"2019","journal-title":"Med Clin North Am"},{"key":"key20240516111816_b16-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"819790","DOI":"10.3389\/fonc.2022.819790","article-title":"Elevated levels of soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and systemic inflammatory stress as potential contributors to immune suppression and generalized tumorigenesis in a cohort of South African xeroderma pigmentosum patients","volume":"12","author":"Kgokolo","year":"2022","journal-title":"Front Oncol"},{"key":"key20240516111816_b17-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"10422","DOI":"10.1158\/0008-5472.CAN-10-2615","article-title":"p53 dysfunction by xeroderma pigmentosum group c defects enhance lung adenocarcinoma metastasis via increased Mmp1 expression","volume":"70","author":"Wu","year":"2010","journal-title":"Cancer Res"},{"key":"key20240516111816_b18-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.1016\/j.cllc.2019.01.002","article-title":"Ex Vivo Interferon gamma production by peripheral immune cells predicts survival in lung adenocarcinoma","volume":"20","author":"Ahn","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"key20240516111816_b19-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"108784","DOI":"10.1016\/j.celrep.2021.108707","article-title":"Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK\/RAS\/RAF pathway","volume":"34","author":"Carrot-Zhang","year":"2021","journal-title":"Cell Rep"},{"key":"key20240516111816_b20-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","article-title":"User's guide to correlation coefficients","volume":"18","author":"Akoglu","year":"2018","journal-title":"Turk J Emerg Med"},{"key":"key20240516111816_b21-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jtho.2023.01.088","article-title":"IASLC lung cancer staging project: The new database to inform revisions in the Ninth Edition of the TNM classification of lung cancer","volume":"18","author":"Asamura","year":"2023","journal-title":"J Thorac Oncol"},{"key":"key20240516111816_b22-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.hoc.2016.08.006","article-title":"Lung cancer biomarkers","volume":"31","author":"Villalobos","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"key":"key20240516111816_b23-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12859-022-04869-7","article-title":"Development and validation of the potential biomarkers based on m6A-related lncRNAs for the predictions of overall survival in the lung adenocarcinoma and differential analysis with cuproptosis","volume":"23","author":"Gao","year":"2022","journal-title":"BMC Bioinformatics"},{"key":"key20240516111816_b24-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.path.2019.11.002","article-title":"Targeted therapy and checkpoint immunotherapy in lung cancer","volume":"13","author":"Ruiz-Cordero","year":"2020","journal-title":"Surg Pathol Clin"},{"key":"key20240516111816_b25-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-3-319-40389-2_2","article-title":"Diagnosis and molecular classification of lung cancer","volume":"170","author":"Rodriguez-Canales","year":"2016","journal-title":"Cancer Treat Res"},{"key":"key20240516111816_b26-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/jcmm.14719","article-title":"Systematic construction and validation of an immune prognostic model for lung adenocarcinoma","volume":"24","author":"Luo","year":"2020","journal-title":"J Cell Mol Med"},{"key":"key20240516111816_b27-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2012.08.014","article-title":"Lung cancer stem cells: Progress and prospects","volume":"338","author":"Lundin","year":"2013","journal-title":"Cancer Lett"},{"key":"key20240516111816_b28-ol-27-6-14392","article-title":"XPC: Its Product and Biological Roles","volume-title":"Molecular Mechanisms of Xeroderma Pigmentosum. Advances in Experimental Medicine and Biology","author":"Sugasawa","year":"2008"},{"key":"key20240516111816_b29-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.dnarep.2015.09.004","article-title":"XPC: Going where no DNA damage sensor has gone before","volume":"36","author":"Nemzow","year":"2015","journal-title":"DNA Repair (Amst)"},{"key":"key20240516111816_b30-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"10060","DOI":"10.18632\/oncotarget.3542","article-title":"XPC inhibits NSCLC cell proliferation and migration by enhancing E-Cadherin expression","volume":"6","author":"Cui","year":"2015","journal-title":"Oncotarget"},{"key":"key20240516111816_b31-ol-27-6-14392","first-page":"1875","article-title":"XPC inhibition rescues cisplatin resistance via the Akt\/mTOR signaling pathway in A549\/DDP lung adenocarcinoma cells","volume":"41","author":"Teng","year":"2019","journal-title":"Oncol Rep"},{"key":"key20240516111816_b32-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"846965","DOI":"10.3389\/fonc.2022.846965","article-title":"Xeroderma pigmentosum complementation group C (XPC): Emerging roles in non-dermatologic malignancies","volume":"12","author":"Nasrallah","year":"2022","journal-title":"Front Oncol"},{"key":"key20240516111816_b33-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ccell.2018.09.003","article-title":"Complement C5a fosters squamous carcinogenesis and limits T cell response to chemotherapy","volume":"34","author":"Medler","year":"2018","journal-title":"Cancer Cell"},{"key":"key20240516111816_b34-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrclinonc.2016.211","article-title":"Radiotherapy and immunotherapy: A beneficial liaison?","volume":"14","author":"Weichselbaum","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"key20240516111816_b35-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/S0959-8049(97)88065-3","article-title":"Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: Enhancement of effect by batimastat","volume":"33","author":"Burke","year":"1997","journal-title":"EJC"},{"key":"key20240516111816_b36-ol-27-6-14392","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","article-title":"Regulation of interferon-gamma during innate and adaptive immune responses","volume":"96","author":"Schoenborn","year":"2007","journal-title":"Adv Immunol"},{"key":"key20240516111816_b37-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ijc.1310","article-title":"IFN-gamma induces cell death in human hepatoma cells through a TRAIL\/death receptor-mediated apoptotic pathway","volume":"93","author":"Shin","year":"2001","journal-title":"Int J Cancer"},{"key":"key20240516111816_b38-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cell.2016.03.031","article-title":"Combination cancer therapies with immune checkpoint blockade: Convergence on interferon signaling","volume":"165","author":"Minn","year":"2016","journal-title":"Cell"},{"key":"key20240516111816_b39-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10238-016-0432-3","article-title":"IFNs-signaling effects on lung cancer: An up-to-date pathways-specific review","volume":"17","author":"Galani","year":"2017","journal-title":"Clin Exp Med"},{"key":"key20240516111816_b40-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.3390\/ijerph18179345","article-title":"Interferon-\u04af-Inducible chemokines as prognostic markers for lung cancer","volume":"18","author":"Lee","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"key20240516111816_b41-ol-27-6-14392","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1158\/0008-5472.CAN-19-0596","article-title":"Low-Dose IFN\u04af induces tumor cell stemness in tumor microenvironment of non-small cell lung cancer","volume":"79","author":"Song","year":"2019","journal-title":"Cancer Res"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T08:19:27Z","timestamp":1715847567000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,4,9]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14392","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,9]]},"article-number":"259"}}